Perspective Therapeutics, Inc. (CATX)
2.88
0.00 (0.00%)
USD |
NYAM |
Sep 18, 16:00
2.93
+0.05
(+1.74%)
After-Hours: 20:00
Perspective Therapeutics 30-Day Average Daily Volume : 1.535M for Sept. 18, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.535M |
| September 17, 2026 | 1.164M |
| September 16, 2026 | 1.182M |
| September 15, 2026 | 1.206M |
| September 14, 2026 | 1.186M |
| September 11, 2026 | 1.146M |
| September 10, 2026 | 1.099M |
| September 09, 2026 | 1.081M |
| September 08, 2026 | 1.064M |
| September 04, 2026 | 1.056M |
| September 03, 2026 | 1.033M |
| September 02, 2026 | 1.021M |
| September 01, 2026 | 1.031M |
| August 31, 2026 | 1.036M |
| August 28, 2026 | 1.037M |
| August 27, 2026 | 1.040M |
| August 26, 2026 | 1.062M |
| August 25, 2026 | 1.085M |
| August 24, 2026 | 1.153M |
| August 21, 2026 | 1.259M |
| August 20, 2026 | 1.315M |
| August 19, 2026 | 1.380M |
| August 18, 2026 | 1.392M |
| August 17, 2026 | 1.429M |
| August 14, 2026 | 1.435M |
| Date | Value |
|---|---|
| August 13, 2026 | 1.455M |
| August 12, 2026 | 1.468M |
| August 11, 2026 | 1.502M |
| August 10, 2026 | 1.500M |
| August 07, 2026 | 1.793M |
| August 06, 2026 | 1.814M |
| August 05, 2026 | 1.853M |
| August 04, 2026 | 1.842M |
| August 03, 2026 | 1.844M |
| July 31, 2026 | 2.070M |
| July 30, 2026 | 2.111M |
| July 29, 2026 | 2.116M |
| July 28, 2026 | 2.140M |
| July 27, 2026 | 2.141M |
| July 24, 2026 | 2.149M |
| July 23, 2026 | 2.164M |
| July 22, 2026 | 2.195M |
| July 21, 2026 | 2.198M |
| July 20, 2026 | 2.231M |
| July 17, 2026 | 2.322M |
| July 16, 2026 | 2.321M |
| July 15, 2026 | 2.305M |
| July 14, 2026 | 2.305M |
| July 13, 2026 | 2.241M |
| July 10, 2026 | 2.155M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Anika Therapeutics, Inc. | 104919.0 |
| MiMedx Group, Inc. | 1.116M |
| ABVC BioPharma, Inc. | 129899.2 |
| Enovis Corp. | 1.620M |
| Edwards Lifesciences Corp. | 3.030M |